Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $2.92 and traded as high as $4.80. AIkido Pharma shares last traded at $4.32, with a volume of 197,919 shares.
AIkido Pharma Stock Down 6.1 %
The stock has a fifty day simple moving average of $5.20 and a 200 day simple moving average of $2.92. The firm has a market capitalization of $23.70 million, a P/E ratio of -1.11 and a beta of 0.93.
AIkido Pharma Company Profile
AIkido Pharma Inc, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia.
Read More
- Five stocks we like better than AIkido Pharma
- What is a Death Cross in Stocks?
- FedEx Delivers Another Crushing Blow to Its Stock Price
- What is a support level?
- Analysts Stay Bullish on Rocket Lab as Signs of a Bottom Emerge
- Best Stocks Under $10.00
- Micron Stock Will Retest All-Time Highs This Year
Receive News & Ratings for AIkido Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AIkido Pharma and related companies with MarketBeat.com's FREE daily email newsletter.